Novel epitope evoking CD138 antigen-specific cytotoxic T lymphocytes targeting multiple myeloma and other plasma cell disorders.
about
Molecular and clinical profiles of syndecan-1 in solid and hematological cancer for prognosis and precision medicineDendritic Cell-Based Cancer Immunotherapy against Multiple Myeloma: From Bench to ClinicNew strategies in the treatment of multiple myeloma.Human heat shock protein-specific cytotoxic T lymphocytes display potent antitumour immunity in multiple myeloma.A multiepitope of XBP1, CD138 and CS1 peptides induces myeloma-specific cytotoxic T lymphocytes in T cells of smoldering myeloma patientsThe antigenic landscape of multiple myeloma: mass spectrometry (re)defines targets for T-cell-based immunotherapyDissecting the multiple myeloma-bone microenvironment reveals new therapeutic opportunitiesA novel immunogenic CS1-specific peptide inducing antigen-specific cytotoxic T lymphocytes targeting multiple myeloma.Myeloma-specific multiple peptides able to generate cytotoxic T lymphocytes: a potential therapeutic application in multiple myeloma and other plasma cell disorders.Immunotherapy for multiple myeloma.T cell-based targeted immunotherapies for patients with multiple myeloma.Overcoming multiple myeloma drug resistance in the era of cancer 'omics'.Identification of human leucocyte antigen (HLA)-A*0201-restricted cytotoxic T lymphocyte epitopes derived from HLA-DOβ as a novel target for multiple myelomaDendritic cell cancer vaccines: from the bench to the bedside.Identification and characterization of HLA-A24-specific XBP1, CD138 (Syndecan-1) and CS1 (SLAMF7) peptides inducing antigens-specific memory cytotoxic T lymphocytes targeting multiple myeloma.
P2860
Q26796247-CE5C6946-243E-470D-B60E-AA7D20A0855AQ27023621-37E9E9A4-9B77-4859-BAEA-18162E9D22E6Q33958520-C1092862-EAB0-4832-BA1E-2D49F17E3F68Q34052565-D95BCFCE-9FE7-47D5-9BD0-F224B8104897Q34543937-56DF0410-D8E3-4780-AA3C-02B7314C8687Q36169794-D54C0BE4-B040-46F2-9ED3-9EDC11ABE78DQ36447553-D00031D2-8D0D-4207-A94E-479336789E67Q37284373-F0FF7561-AA0D-4D4F-9E33-D2316DAAD3FDQ37340304-D54BDA5E-9B4A-4B0E-9B34-6394C707C81DQ38177879-5067BC64-77F6-496A-8665-44A473F849EAQ38246639-BD1AA462-4EA3-453D-802B-6BE691BBDE32Q38671390-1FDB45D1-6B6B-49FB-A1AB-427364691A2BQ42287234-C5F01F7E-A321-4967-B007-ABC1B7624452Q42979673-32A52C39-054A-48B8-9F94-88D02758FAD2Q47580433-8E72A0DF-DB0F-49AB-AF29-54E81418130C
P2860
Novel epitope evoking CD138 antigen-specific cytotoxic T lymphocytes targeting multiple myeloma and other plasma cell disorders.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Novel epitope evoking CD138 an ...... d other plasma cell disorders.
@en
Novel epitope evoking CD138 an ...... d other plasma cell disorders.
@nl
type
label
Novel epitope evoking CD138 an ...... d other plasma cell disorders.
@en
Novel epitope evoking CD138 an ...... d other plasma cell disorders.
@nl
prefLabel
Novel epitope evoking CD138 an ...... d other plasma cell disorders.
@en
Novel epitope evoking CD138 an ...... d other plasma cell disorders.
@nl
P2093
P2860
P1476
Novel epitope evoking CD138 an ...... d other plasma cell disorders.
@en
P2093
Jooeun Bae
Nikhil C Munshi
Yu-Tzu Tai
P2860
P304
P356
10.1111/J.1365-2141.2011.08850.X
P407
P577
2011-09-09T00:00:00Z